Polymerase chain reaction for detection of Mycobacterium tuberculosis

Sjöbring, Ulf; Mecklenburg, Michael; Andersen, Åse Bengård; Miörner, Håkan

doi:10.1128/jcm.28.10.2200-2204.1990

Cited by 157 publications

(68 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The specificity of the PCR amplification process lies in the choice of primers used. Numerous PCR-based assays for the detection and identification of individual mycobacterium species, such as M. tuberculosis, M. leprae, and M. avium, have been described (2,3,(34)(35)(36)(37)(38)(39)(40)(41)(42)(43)(44)(45)(46)(47). Many target sequences have been used, but the most thoroughly evaluated assays target the M. tuberculosisspecific repeated DNA element IS 6110 (40).…”

Section: Approaches Based On Molecular Biologymentioning

confidence: 99%

Diagnosis of tuberculosis: Available technologies, limitations, and possibilities

Garg

Tiwari

et al. 2003

Clinical Laboratory Analysis

View full text Add to dashboard Cite

Rapid diagnosis and treatment are important for preventing transmission of Mycobacterium tuberculosis. However, the diagnosis of tuberculosis continues to pose serious problems, mainly because of difficulties in differentiating between patients with active tuberculosis and those with healed lesions, normal mycobacterium boris BCG (Bacillus Calmette Guerin) vaccinated individuals, and unvaccinated Manteux positives. Physicians still rely on conventional methods such as Ziehl-Neelsen (ZN) staining, fluorochrome staining, sputum culture, gastric lavage, and other non-traditional methods. Although the tuberculin test has aided in the diagnosis of tuberculosis for more than 85 years, its interpretation is difficult because sensitization with nontuberculous mycobacteria leads to false-positive tests. There have been numerous unsuccessful attempts to develop clinically useful serodiagnostic kits for tuberculosis. A number of proteinaceous and nonprotein antigens (such as acyltrehaloses and phenolglycolipids) have been explored from time to time for the development of such assays but they have not proved to be clinically useful. It has been difficult to develop an ELISA utilizing a suitable antigen because M. tuberculosis shares a large number of antigenic proteins with other microorganisms that may or may not be pathogenic. With the advent of molecular biology techniques, there have been significant advances in nucleic acid-based amplification and hybridization, which are helping to rectify existing flaws in the diagnosis of tuberculosis. The detection of mycobacterial DNA in clinical samples by polymerase chain reaction (PCR) is a promising approach for the rapid diagnosis of tuberculous infection. However, the PCR results must be corrected for the presence of inhibitors as well as for DNA contamination. In the modern era of genetics, marked by proteomics and genomics, the day is not far off when DNA chip-based hybridization assays will instantly reveal mycobacterial infections.

show abstract

Section: Approaches Based On Molecular Biologymentioning

confidence: 99%

Diagnosis of tuberculosis: Available technologies, limitations, and possibilities

Garg

Tiwari

et al. 2003

Clinical Laboratory Analysis

View full text Add to dashboard Cite

show abstract

“…However, the pretreatment methods were quite divergent. Sjobring et al used long centrifugation and sonication steps, in addition to boiling, to detect down to eight organisms [171]. Sritharan et al was able to cut down the steps to a 30 min boiling period, with a resulting LOD of 1 organism [172].…”

Section: Direct Naats For Saliva and Sputummentioning

confidence: 99%

Advances in Directly Amplifying Nucleic Acids from Complex Samples

Walker

Hsieh

2019

Biosensors

View full text Add to dashboard Cite

Advances in nucleic acid amplification technologies have revolutionized diagnostics for systemic, inherited, and infectious diseases. Current assays and platforms, however, often require lengthy experimental procedures and multiple instruments to remove contaminants and inhibitors from clinically-relevant, complex samples. This requirement of sample preparation has been a bottleneck for using nucleic acid amplification tests (NAATs) at the point of care (POC), though advances in "lab-on-chip" platforms that integrate sample preparation and NAATs have made great strides in this space. Alternatively, direct NAATs-techniques that minimize or even bypass sample preparation-present promising strategies for developing POC diagnostic tools for analyzing real-world samples. In this review, we discuss the current status of direct NAATs. Specifically, we surveyed potential testing systems published from 1989 to 2017, and analyzed their performances in terms of robustness, sensitivity, clinical relevance, and suitability for POC diagnostics. We introduce bubble plots to facilitate our analysis, as bubble plots enable effective visualization of the performances of these direct NAATs. Through our review, we hope to initiate an in-depth examination of direct NAATs and their potential for realizing POC diagnostics, and ultimately transformative technologies that can further enhance healthcare.

show abstract

“…Conventional methods of identifying Mycobacterium tuberculosis require up to 6 weeks, yet with primers designed for diffcrent segments in the bacterium genome (antigen B; MPB64), such analysis can be completed within a few hours (52). Highly sencitive detection of M .…”

Section: Bacteriamentioning

confidence: 99%